Long-Term Endothelin-A Receptor Antagonism Provides Robust Renal Protection in Humanized Sickle Cell Disease Mice.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of the American Society of Nephrology

• Publication date

  2017-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1681/ASN.2016070711PMID 28348063PMCID PMC5533228
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endothelin

  2016cited by this paper
• Extracellular purines' action on glomerular albumin permeability in isolated rat glomeruli: insights into the pathogenesis of albuminuria.

  2016cited by this paper
• Endothelin receptor antagonists in sickle cell disease: A promising new therapeutic approach.

  2016cited by this paper
• Endothelin‐1 contributes to the progression of renal injury in sickle cell disease via reactive oxygen species

  2016cited by this paper
• Endothelin Receptors and Their Antagonists

  2015cited by this paper
• Utility of Iron Staining in Identifying the Cause of Renal Allograft Dysfunction in Patients with Sickle Cell Disease

  2015cited by this paper
• Endothelin and renal ion and water transport.

  2015cited by this paper
• ET‐1 increases reactive oxygen species following hypoxia and high‐salt diet in the mouse glomerulus

  2015cited by this paper
• Transcutaneous measurement of glomerular filtration rate in small rodents: Through the skin for the win?

  2015cited by this paper
• Sickle cell disease: renal manifestations and mechanisms

  2015cited by this paper
• Endothelium-derived ET-1 and the development of renal injury.

  2015cited by this paper
• Prevalence and Progression of Chronic Kidney Disease in Adult Patients With Sickle Cell Disease

  2014cited by this paper
• The proximal tubule and albuminuria: really!

  2014cited by this paper
• Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosis.

  2014cited by this paper
• Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.

  2014cited by this paper
• Factors associated with survival in a contemporary adult sickle cell disease cohort

  2014cited by this paper
• The Role of Endothelin-1 and Endothelin Receptor Antagonists in Inflammatory Response and Sepsis

  2014cited by this paper
• Endothelin 1 in cancer: biological implications and therapeutic opportunities

  2013cited by this paper
• Mortality Rates and Age at Death from Sickle Cell Disease: U.S., 1979–2005

  2013cited by this paper
• Insulin increases glomerular filtration barrier permeability through dimerization of protein kinase G type Iα subunits.

  2013cited by this paper
• Sickle cell disease related mortality in the United States (1999–2009)

  2013cited by this paper
• Selective Endothelin-A Receptor Antagonism Reduces Proteinuria, Blood Pressure, and Arterial Stiffness in Chronic Proteinuric Kidney Disease

  2011cited by this paper
• Cellular pathophysiology of ischemic acute kidney injury.

  2011cited by this paper
• Biomarkers for early detection of sickle nephropathy

  2011cited by this paper
• Regulation of blood pressure and salt homeostasis by endothelin.

  2011cited by this paper
• Distinct Actions of Endothelin A-Selective Versus Combined Endothelin A/B Receptor Antagonists in Early Diabetic Kidney Disease

  2011cited by this paper
• Dynamin activates NO production in rat renal inner medullary collecting ducts via protein-protein interaction with NOS1.

  2011cited by this paper
• Population estimates of sickle cell disease in the U.S.

  2010cited by this paper
• Early and prominent alterations in hemodynamics, signaling, and gene expression following renal ischemia in sickle cell disease.

  2010cited by this paper
• Endothelin-1 Increases Glomerular Permeability and Inflammation Independent of Blood Pressure in the Rat

  2010cited by this paper
• Endothelin receptors and pain.

  2009cited by this paper
• Avosentan reduces albumin excretion in diabetics with macroalbuminuria.

  2009cited by this paper
• The Molecular Interactions between Filtered Proteins and Proximal Tubular Cells in Proteinuria

  2008cited by this paper
• Inhibition of endothelin receptors in the treatment of pulmonary arterial hypertension: does selectivity matter?

  2008cited by this paper
• Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease.

  2008cited by this paper
• Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells.

  2008cited by this paper
• Mortality at Low and High Estimated Glomerular Filtration Rate Values: A ‘U’ Shaped Curve

  2008cited by this paper
• Proteinuria in children with sickle cell disease.

  2007cited by this paper
• Clinical impact of research on the podocyte slit diaphragm

  2006cited by this paper
• Diabetic endothelin B receptor-deficient rats develop severe hypertension and progressive renal failure.

  2006cited by this paper
• Correction of sickle cell disease by homologous recombination in embryonic stem cells.

  2006cited by this paper
• Shigatoxin-induced endothelin-1 expression in cultured podocytes autocrinally mediates actin remodeling.

  2006cited by this paper
• Urinary endothelin-1 as a marker of renal damage in sickle cell disease.

  2005cited by this paper
• Endothelin‐1 enhances oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: role of ETB receptor, NADPH oxidase and caveolin‐1

  2005cited by this paper
• In response to protein load podocytes reorganize cytoskeleton and modulate endothelin-1 gene: implication for permselective dysfunction of chronic nephropathies.

  2005cited by this paper
• Exaggerated Vascular and Renal Pathology in Endothelin-B-receptor-deficient Rats with Subtotal Nephrectomy

  2004cited by this paper
• Role of Podocytes for Reversal of Glomerulosclerosis and Proteinuria in the Aging Kidney After Endothelin Inhibition

  2004cited by this paper
• ETA receptor blockade induces tubular cell proliferation and cyst growth in rats with polycystic kidney disease.

  2003cited by this paper
• Tubular injury in glomerular disease.

  2003cited by this paper
• Inherited haemoglobin disorders: an increasing global health problem.

  2001cited by this paper
• Evidence for endothelin involvement in the response to high salt.

  2001cited by this paper
• Glomerulosclerosis and progression: effect of subantihypertensive doses of alpha and beta blockers.

  2001cited by this paper
• Glomerulosclerosis and progression: Effect of subantihypertensive doses of α and βblockers

  2001cited by this paper
• Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis.

  2001cited by this paper
• Renal abnormalities in sickle cell disease

  2000cited by this paper
• Hypertensive response to chronic NO synthase inhibition is different in Sprague-Dawley rats from two suppliers.

  1998cited by this paper
• Urinary endothelin in adolescents and young adults with insulin-dependent diabetes mellitus: relation to urinary albumin, blood pressure, and other factors.

  1998cited by this paper
• Apoptosis in kidneys of endothelin-1 transgenic mice.

  1998cited by this paper
• Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis.

  1998cited by this paper
• Pathophysiology of progressive nephropathies.

  1998cited by this paper
• Molecular Interactions between Albumin and Proximal Tubular Cells

  1998cited by this paper
• Increased levels of endothelin-1 in plasma of sickle cell anemia patients.

  1998cited by this paper
• Increased Levels of Endothelin-1 in Plasma of Sickle Cell Anemia Patients

  1998cited by this paper
• Endothelin-1 production during the acute chest syndrome in sickle cell disease.

  1997cited by this paper
• Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension.

  1997cited by this paper
• Early detection and the course of glomerular injury in patients with sickle cell anemia.

  1996cited by this paper
• Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins.

  1995cited by this paper
• Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney.

  1993cited by this paper
• A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression.

  1993cited by this paper
• Measurement of albumin reflection coefficient with isolated rat glomeruli.

  1992cited by this paper
• Literature abstracts

  1991cited by this paper
• Molecular biology and biochemistry of the endothelins.

  1989cited by this paper
• Molecular biology and biochemistry of the endothelins.

  1989cited by this paper
• A novel potent vasoconstrictor peptide produced by vascular endothelial cells

  1988cited by this paper
• Role of hypertension in progressive glomerular immune injury.

  1985cited by this paper
• Isolation of Glomeruli from Mammalian Kidneys by Graded Sieving

  1972cited by this paper
• Isolation of glomeruli from mammalian kidneys by graded sieving.

  1972cited by this paper

• Increased Endothelin-1 and High-Risk APOL1 Variants Contribute to Albuminuria in Pediatric and Young Adults with Sickle Cell Anemia.

  2026cites this paper
• Modulation of AKT/GSK-3β signaling by ambrisentan alleviates chronic kidney disease.

  2026cites this paper
• Podocyte dysfunction driven by heme in sickle-cell nephropathy

  2025cites this paper
• Endothelin-1 signaling in the kidney: recent advances and remaining gaps.

  2025cites this paper
• Hydroxyurea Mitigates Heme-Induced Inflammation and Kidney Injury in Humanized Sickle Cell Mice

  2025cites this paper
• Addressing the pathophysiology of venous thrombosis and chronic kidney disease in sickle cell trait using a mouse model

  2025cites this paper
• Selective endothelin A receptor antagonism in chronic kidney disease: improving clinical application

  2025cites this paper
• Repurposing the familiar: Future treatment options against chronic kidney disease.

  2025cites this paper
• Inhibition of p75NTR/p53 axis by ambrisentan suppresses apoptosis and oxidative stress-mediated renal damage in a cisplatin AKI model.

  2025cites this paper
• The Influence of PAR 1 and Endothelin 1 on the Course of Specific Kidney Diseases

  2025cites this paper
• Comprehensive analysis of the endothelin system in the kidneys of mice, rats, and humans

  2024cites this paper
• Endothelin receptor antagonists in chronic kidney disease

  2024cites this paper
• Enhanced Vasoconstriction in Sickle Cell Disease is Dependent on ETA Receptor Activation.

  2024cites this paper
• Association of biomarkers of endothelial function, coagulation activation and kidney injury with persistent albuminuria in sickle cell anaemia

  2024cites this paper
• End Organ Affection in Sickle Cell Disease

  2024cites this paper
• Emerging Therapies and Advances in Sickle Cell Disease with a Focus on Renal Manifestations

  2023cites this paper
• Sickle Cell Nephropathy

  2023cites this paper
• Endothelin System in Hypertension and Chronic Kidney Disease

  2023cites this paper
• Sickle Cell Disease and CKD: An Update

  2023cites this paper
• Mouse models of sickle cell disease: Imperfect and yet very informative.

  2023cites this paper
• Sanqi Qushi Granule Alleviates Proteinuria and Podocyte Damage in NS Rat: A Network Pharmacology Study and in vivo Experimental Validation

  2023cites this paper
• Urinary angiotensinogen is associated with albuminuria in adults with sickle cell anaemia

  2023cites this paper
• Endothelin A receptor antagonist attenuated renal iron accumulation in iron overload heme oxygenase-1 knockout mice.

  2022cites this paper
• Endothelin receptor antagonism improves glucose tolerance and adipose tissue inflammation in an experimental model of systemic lupus erythematosus.

  2022cites this paper
• PATHOPHYSIOLOGICAL CHARACTERIZATION OF THE TOWNES MOUSE MODEL FOR SICKLE CELL DISEASE.

  2022cites this paper
• Development and characterization of a preclinical total marrow irradiation conditioning-based bone marrow transplant model for sickle cell disease

  2022cites this paper
• Endothelin System Expression in the Kidney following Cisplatin-Induced Acute Kidney Injury in Male and Female Mice.

  2022cites this paper
• The nephropathy of sickle cell trait and sickle cell disease

  2022cites this paper
• Hydroxyurea Improves Nitric Oxide Bioavailability in Humanized Sickle Cell Mice.

  2021cites this paper
• UAB-UCSD O'Brien Center for Acute Kidney Injury Research.

  2021cites this paper
• Olinciguat, a stimulator of soluble guanylyl cyclase, attenuates inflammation, vaso‐occlusion and nephropathy in mouse models of sickle cell disease

  2021influential citation
• Endothelin receptor antagonists for the treatment of diabetic and nondiabetic chronic kidney disease

  2021influential citation
• Longitudinal study of glomerular hyperfiltration and normalization of estimated glomerular filtration in adults with sickle cell disease

  2021cites this paper
• Kidney iron deposition by R2* is associated with haemolysis and urinary iron

  2020cites this paper
• High molecular weight kininogen contributes to early mortality and kidney dysfunction in a mouse model of sickle cell disease

  2020cites this paper
• Endothelin-targeted new treatments for proteinuric and inflammatory glomerular diseases: focus on the added value to anti-renin-angiotensin system inhibition

  2020cites this paper
• Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy

  2020cites this paper
• Hemolysis induced by Left Ventricular Assist Device is associated with proximal tubulopathy

  2020cites this paper
• A pilot study of the effect of atorvastatin on endothelial function and albuminuria in sickle cell disease

  2019cites this paper
• Hypoxia and Renal Tubulointerstitial Fibrosis.

  2019cites this paper
• Impact of ET-1 and sex in glomerular hyperfiltration in humanized sickle cell mice.

  2019cites this paper
• Sickle cell disease nephropathy: an update on risk factors and potential biomarkers in pediatric patients.

  2019cites this paper
• SONAR propels endothelin A receptor antagonists to success

  2019cites this paper
• Hyperfiltration predicts long-term renal outcomes in humanized sickle cell mice.

  2019cites this paper
• Dynamic changes in histone deacetylases following kidney ischemia-reperfusion injury are critical for promoting proximal tubule proliferation.

  2019cites this paper
• Endothelin: 30 Years From Discovery to Therapy.

  2019cites this paper
• Renal protection by atorvastatin in a murine model of sickle cell nephropathy

  2018cites this paper
• RON kinase inhibition reduces renal endothelial injury in sickle cell disease mice

  2018cites this paper
• Characterization of Renal Injury and Inflammation in an Experimental Model of Intravascular Hemolysis

  2018cites this paper
• Acute Pressor Response to Psychosocial Stress Is Dependent on Endothelium‐Derived Endothelin‐1

  2018cites this paper
• Sickle Cell Nephropathy: Current Understanding of the Presentation, Diagnostic and Therapeutic Challenges

  2018cites this paper
• Sickle Cell Nephropathy in the Pediatric Population

  2018cites this paper
• Tauroursodeoxycholic acid (TUDCA) abolishes chronic high salt‐induced renal injury and inflammation

  2018cites this paper
• Effect of renin‐angiotensin‐aldosterone system blocking agents on progression of glomerulopathy in sickle cell disease

  2018cites this paper
• ETA receptor activation contributes to T cell accumulation in the kidney following ischemia‐reperfusion injury

  2018cites this paper
• Combined hydroxyurea and ETA receptor blockade reduces renal injury in the humanized sickle cell mouse

  2018influential citation
• The role of nitrite in muscle function, susceptibility to contraction injury, and fatigability in sickle cell mice.

  2018cites this paper
• Renoprotective effects of ET(A) receptor antagonists therapy in experimental non-diabetic chronic kidney disease: Is there still hope for the future?

  2018cites this paper
• Effects of living at moderate altitude on pulmonary vascular function and exercise capacity in mice with sickle cell anaemia

  2018cites this paper
• Sickle cell nephropathy: an update on pathophysiology, diagnosis, and treatment

  2018cites this paper
• Endothelium-Neutrophil Communication via B1-Kinin Receptor-Bearing Microvesicles in Vasculitis.

  2017cites this paper
• Mechanisms of complement activation under hemolytic conditions

  2017cites this paper
• The spectrum of sickle hemoglobin-related nephropathy: from sickle cell disease to sickle trait

  2017cites this paper
• Losartan therapy decreases albuminuria with stable glomerular filtration and permselectivity in sickle cell anemia.

  2017cites this paper
• Endothelin-A Receptor Antagonism Retards the Progression of Murine Sickle Cell Nephropathy.

  2017cites this paper